Literature DB >> 17723174

Cancer chemoprevention by phytochemicals: potential molecular targets, biomarkers and animal models.

Ki Han Kwon1, Avantika Barve, Siwang Yu, Mou-Tuan Huang, Ah-Ng Tony Kong.   

Abstract

Recent studies have strongly indicated that certain daily-consumed dietary phytochemicals could have cancer protective effects against transgenic mice cancer models and cancers mediated by carcinogens, irradiations and carcinogenic metabolites derived from exogenous or endogenous sources. The cancer-protective effects elicited by these dietary compounds are believed to be due at least in part to the induction of cellular defense systems including the detoxifying and antioxidant enzymes system, as well as the inhibition of anti-inflammatory and anti-cell growth signaling pathways culminating in cell cycle arrest and/or celldeath. In this review, we summarize the potential mechanisms including the modulation of nuclear factor kappaB (NF-kappaB), cyclooxygenases-2 (COX-2), activator protein-1 (AP-1), mitogen-activated protein kinases (MAPKs) and the induction of phase II cellular detoxifying and antioxidant enzymes mediated mainly by the antioxidant response elements (ARE) within the promoter regions of these genes through nuclear factor-erythroid 2-related factor 2 (Nrf2), a member of the Cap "n" collar (CNC) family of the basic region-leucine zipper transcription factor. In addition, we also review several animal models of carcinogenesis and cancer chemopreventive efficacy studies of these animal models using dietary chemopreventive compounds. Finally, we discuss the cellular signaling cascades mediated by Nrf2, NF-kappaB, AP-1, MAPKs and COX-2, which have been considered to play pivotal roles in tumor initiation, promotion and progression processes, and could be promising molecular targets for the design of drugs targeting cancer prevention and therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17723174     DOI: 10.1111/j.1745-7254.2007.00694.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  34 in total

1.  Epigallocatechin-3-gallate regulates cell growth, cell cycle and phosphorylated nuclear factor-κB in human dermal fibroblasts.

Authors:  Dong-wook Han; Mi Hee Lee; Hak Hee Kim; Suong-hyu Hyon; Jong-chul Park
Journal:  Acta Pharmacol Sin       Date:  2011-04-25       Impact factor: 6.150

Review 2.  Biological reactive intermediates (BRIs) formed from botanical dietary supplements.

Authors:  Birgit M Dietz; Judy L Bolton
Journal:  Chem Biol Interact       Date:  2010-10-21       Impact factor: 5.192

3.  Effect of Metformin, Rapamycin, and Their Combination on Growth and Progression of Prostate Tumors in HiMyc Mice.

Authors:  Achinto Saha; Jorge Blando; Lisa Tremmel; John DiGiovanni
Journal:  Cancer Prev Res (Phila)       Date:  2015-04-23

4.  454 EST analysis detects genes putatively involved in ginsenoside biosynthesis in Panax ginseng.

Authors:  S Chen; H Luo; Y Li; Y Sun; Q Wu; Y Niu; J Song; A Lv; Y Zhu; C Sun; A Steinmetz; Z Qian
Journal:  Plant Cell Rep       Date:  2011-04-12       Impact factor: 4.570

5.  Bornyl caffeate induces apoptosis in human breast cancer MCF-7 cells via the ROS- and JNK-mediated pathways.

Authors:  Chuan-bin Yang; Wei-jing Pei; Jia Zhao; Yuan-yuan Cheng; Xiao-hui Zheng; Jian-hui Rong
Journal:  Acta Pharmacol Sin       Date:  2013-12-16       Impact factor: 6.150

6.  A survey on herbal management of hepatocellular carcinoma.

Authors:  Nabil Mohie Abdel-Hamid; Maiiada Hasan Nazmy; Ahmed Wahid Mahmoud; Michael Atef Fawzy; Marco Youssof
Journal:  World J Hepatol       Date:  2011-07-27

Review 7.  Cancer chemoprevention by natural products: how far have we come?

Authors:  Rajendra G Mehta; Genoveva Murillo; Rajesh Naithani; Xinjian Peng
Journal:  Pharm Res       Date:  2010-03-18       Impact factor: 4.200

8.  Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7,12-dimethylbenz[a]anthracene.

Authors:  Lisa Becks; Misty Prince; Hannah Burson; Christopher Christophe; Mason Broadway; Ken Itoh; Masayuki Yamamoto; Michael Mathis; Elysse Orchard; Runhua Shi; Jerry McLarty; Kevin Pruitt; Songlin Zhang; Heather E Kleiner-Hancock
Journal:  BMC Cancer       Date:  2010-10-08       Impact factor: 4.430

9.  Green Nanotechnology from Cumin Phytochemicals: Generation of Biocompatible Gold Nanoparticles.

Authors:  Kavita Katti; Nripen Chanda; Ravi Shukla; Ajit Zambre; Thilakavathi Suibramanian; Rajesh R Kulkarni; Raghuraman Kannan; Kattesh V Katti
Journal:  Int J Green Nanotechnol Biomed       Date:  2009-01-01

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.